- MyIllumina
- Tools
Illumina LIMS provides positive sample tracking, project and data management, lab workflow management, and reporting for Infinium Whole-Genome Genotyping, Infinium iSelect, and GoldenGate Genotyping products on a single architecture. The scalable design enables labs to rapidly increase throughout to meet increasing demands. With an easy-to-use interface, LIMS offers greater confidence, reliability, and efficiency for mid- to high-throughput genotyping customers. In addition, LIMS ensures the consistent quality of results required by cytogenetic labs.
- Reliability: Eliminate human errors and sample mix-ups with positive sample tracking from DNA sample input to data output
- Confidence: Remain current with new product launches and receive top-notch support from Illumina's technical support team
- Efficiency: Benefit from real-time quality metrics and the ability to requeue samples; ready-to-use
- Workflow management: Optimize technician time to focus on quality and analysis instead of tracking errors with rigorous, automated lab workflow management
Important Information
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.